Use of serum prolactin in diagnosing epileptic seizures. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Use of serum prolactin in diagnosing epileptic seizures. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
27 October 2008
American Academy of Neurology - Medical Specialty Society
Summary, Pubmed,
GUIDELINE OBJECTIVE(S)
To review the use of serum prolactin assay in epileptic seizure diagnosis
TARGET POPULATION
Adults and older children who have experienced seizures or seizure-like events
INTERVENTIONS AND PRACTICES CONSIDERED
Serum prolactin assay
MAJOR OUTCOMES CONSIDERED
* Usefulness of serum prolactin assay in differentiating epileptic seizures from psychogenic non-epileptic seizures
* Effect of other neurologic changes (e.g., syncope, repetitive seizures, and neonatal seizures) on serum prolactin levels.
American Academy of Neurology - Medical Specialty Society
Summary, Pubmed,
GUIDELINE OBJECTIVE(S)To review the use of serum prolactin assay in epileptic seizure diagnosis
TARGET POPULATION
Adults and older children who have experienced seizures or seizure-like events
INTERVENTIONS AND PRACTICES CONSIDERED
Serum prolactin assay
MAJOR OUTCOMES CONSIDERED
* Usefulness of serum prolactin assay in differentiating epileptic seizures from psychogenic non-epileptic seizures
* Effect of other neurologic changes (e.g., syncope, repetitive seizures, and neonatal seizures) on serum prolactin levels.
Specialities:
- Neurology
- ADHD
- Advanced Parkinson's Disease
- Anxiety Disorder
- Brain Cancer
- Cerebrovascular Disease
- Dementia
- Epilepsy
- Mood Disorders
- Motor/Movement Disorder
- Multiple Sclerosis
- Neuroimaging
- Neurosurgery
- Obsessive-Compulsive Disorder
- Pain/Headache
- Parkinson's Disease
- Psychiatry
- Schizophrenia
- Sleep Disorder
- Stroke
- 16 February 2012
- 1 March 2012
- 1 March 2012










